Analysts at RBC Capital Reconfirmed their Hold rating for Dr Pepper (DPS) with $91.0000 Target; Navidea Biopharmaceuticals (NYSEMKT:NAVB) SI Decreased By 1.04%

July 17, 2017 - By Migdalia James

Among 18 analysts covering Dr Pepper Snapple (NYSE:DPS), 9 have Buy rating, 0 Sell and 9 Hold. Therefore 50% are positive. Dr Pepper Snapple has $116 highest and $84 lowest target. $97.07’s average target is 7.47% above currents $90.32 stock price. Dr Pepper Snapple had 41 analyst reports since July 21, 2015 according to SRatingsIntel. Jefferies maintained Dr Pepper Snapple Group Inc. (NYSE:DPS) rating on Tuesday, May 30. Jefferies has “Buy” rating and $11200 target. The stock of Dr Pepper Snapple Group Inc. (NYSE:DPS) earned “Buy” rating by Sterne Agee CRT on Tuesday, July 21. Susquehanna maintained it with “Hold” rating and $9200 target in Friday, May 26 report. The stock of Dr Pepper Snapple Group Inc. (NYSE:DPS) earned “Outperform” rating by Credit Suisse on Friday, September 16. The rating was upgraded by CLSA to “Outperform” on Friday, January 22. The rating was upgraded by Evercore on Monday, October 5 to “Buy”. The firm has “Buy” rating given on Wednesday, April 19 by Jefferies. The firm earned “Hold” rating on Monday, May 1 by Barclays Capital. Jefferies maintained Dr Pepper Snapple Group Inc. (NYSE:DPS) on Thursday, July 6 with “Buy” rating. The rating was upgraded by RBC Capital Markets on Tuesday, October 27 to “Sector Perform”.

Navidea Biopharmaceuticals Incorporated (NYSEMKT:NAVB) had a decrease of 1.04% in short interest. NAVB’s SI was 12.74 million shares in July as released by FINRA. Its down 1.04% from 12.87M shares previously. With 448,700 avg volume, 28 days are for Navidea Biopharmaceuticals Incorporated (NYSEMKT:NAVB)’s short sellers to cover NAVB’s short positions. The SI to Navidea Biopharmaceuticals Incorporated’s float is 9.54%. The stock decreased 1.25% or $0.006 on July 14, reaching $0.482. About shares traded. Navidea Biopharmaceuticals Inc (NYSEMKT:NAVB) has declined 47.35% since July 17, 2016 and is downtrending. It has underperformed by 64.05% the S&P500.

The stock increased 0.97% or $0.87 on July 14, reaching $90.32. About shares traded. Dr Pepper Snapple Group Inc. (NYSE:DPS) has declined 1.39% since July 17, 2016 and is downtrending. It has underperformed by 18.09% the S&P500.

Analysts await Dr Pepper Snapple Group Inc. (NYSE:DPS) to report earnings on July, 27 before the open. They expect $1.27 EPS, up 1.60% or $0.02 from last year’s $1.25 per share. DPS’s profit will be $235.66 million for 17.78 P/E if the $1.27 EPS becomes a reality. After $1.01 actual EPS reported by Dr Pepper Snapple Group Inc. for the previous quarter, Wall Street now forecasts 25.74% EPS growth.

Dr Pepper Snapple Group, Inc. is an integrated brand owner, maker and distributor of non-alcoholic beverages in the United States, Mexico and Canada. The company has market cap of $16.76 billion. The Firm offers a diverse portfolio of flavored carbonated soft drinks (CSDs) and non-carbonated beverages (NCBs), including ready-to-drink teas, juices, juice drinks, water and mixers. It has a 19.91 P/E ratio. The Company’s divisions include Beverage Concentrates, Packaged Beverages and Latin America Beverages.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.